Newly Created Position to Drive Customer Acquisition for Its Bioengineering and Manufacturing of Custom OrganismsCompany Also Adds Industry Veteran John Pierce as AdvisorSan Diego, CA – April 18, 2016 -Ginkgo Bioworks, a leading organism design company bringing biology to industrial engineering, today at the World Congress on Biotechnology, announced Peter Boynton will join the company as Chief Commercialization Officer early this summer. In addition, the company also announced industry veteran John Pierce has joined as an advisor. These new senior level professionals bring a tremendous amount of expertise to Ginkgo to help fuel the company’s growth and expansion into industrial strain improvement, enzymes, and commodity chemicals.“We are rapidly growing our customer base, delivering improved strains and new products across many sectors including food, fragrance, and consumer goods and are now expanding to industrial enzymes and commodity chemicals,” said Jason Kelly, CEO and Co-Founder, Ginkgo Bioworks. “Peter brings years of experience and his knowledge and expertise in the areas of flavors, fragrances and sweeteners will help us further scale our foundry-based approach for delivering organisms to our customers. We are also fortunate to have John Pierce join us as an advisor and bring his expertise in large scale fermentation and commodity chemicals to Ginkgo.”In his new role as Chief Commercialization Officer, Peter Boynton will be responsible for further scaling Ginkgo’s foundry-based approach for delivering organisms to partners. Boynton will also build a sales team and processes to manage key customer relationships across various sectors. Boynton joins Ginkgo from Tate & Lyle, where he most recently was responsible for managing the company’s relationship with a key global account. Previously, Boynton spent four years as Chief Commercial Officer at Amyris, where he led sales and business development in flavors and fragrances. Prior, Boynton was Senior Vice President of bio-products and fermentation at Tate & Lyle, and an executive at Cargill. Boynton has also served on Ginkgo’s Board of Directors for more than two years.“Ginkgo Bioworks is at the forefront of bringing biology to technology in so many real world applications,” said Peter Boynton, Chief Commercialization Officer, Ginkgo Bioworks. “Since serving on Ginkgo’s Board for the last two years, I’ve seen firsthand the tremendous opportunity in the market for the company’s approach to organism design, and I’m looking forward to leveraging my previous experience to help the company grow even further.”Additionally, John Pierce joins Ginkgo as an advisor with a wealth of expertise and a detailed understanding of multiple sectors, including commodity chemicals, as well as insight into the various technological approaches involved in the development and commercialization of large-scale fermentation processes. Pierce is currently Chairman of the Board for Global Bioenergies, a company focused on commercialization of renewable hydrocarbons, and previously served as Chief Bioscientist at BP as well as Vice President of Applied Biosciences and Director of Biochemical Sciences and Engineering at DuPont. Pierce will help bolster Ginkgo’s business development and partner relations as the company expands to new market sectors.

About Ginkgo Bioworks

Ginkgo Bioworks is an organism design company that is building organisms to specification for customers across markets including food, health and consumer goods. The company’s organism engineers work directly with customers including Fortune 500 companies to design microbes for their specific needs. Ginkgo Bioworks is based in Boston and is financially backed by Viking Global, Felicis Ventures, OS Fund and Y Combinator, as well as a number of angel investors and funds. For more information, visit www.ginkgobioworks.com or follow our Twitter feed at http://twitter.com/Ginkgoo.